RICHMOND, VA--(Marketwired - Jul 22, 2013) - ALR Technologies Inc. (
Providers should note that some patients might require the more intensive monitoring provided by the CGM systems. Therefore these trial results are not meant to demonstrate that the two technologies are interchangeable, only that IBGMS may be a cost effective option for many patients who do not require CGM.
The Webinar is linked here:
http://www.alrt.com/products/HEC-ClinicalSupport
About ALR Technologies Inc.
ALR Technologies is a medical device company providing remote monitoring and care facilitation for patients with chronic diseases. ALRT has developed the FDA-cleared and HIPAA compliant Health-e-Connect System that collects data from blood glucose meters and uploads to a secure website. Trained Facilitators use the System to effect efficiency of care among patients, clinicians and caregivers to improve outcomes and assist health plans to optimize their HEDIS goals. Currently, the Company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data.
This release contains certain "forward-looking statements" relating to ALR Technologies' business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words "estimate", "expect", "anticipate", "believe" and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company's quarterly filings with the Securities Exchange.
Contact Information:
Contact:
Bill Smith
bill.smith@alrt.com
203.762.1073